For eighteen years, a young woman named Lucia moved through the medical system carrying a constellation of mismatched diagnoses, each one a partial answer to a question no one had yet learned to ask correctly. It was not until whole genome sequencing at Cleveland Clinic's Undiagnosed Disease Clinic revealed a mutation in her PPP2R5D gene that the true name emerged: Jordan syndrome, a neurodevelopmental disorder so rare that fewer than five hundred people in the world share it. Her story is a quiet indictment of medicine's limits and a testament to what becomes possible when a parent refuses to
CBS News
· May 24, 2026
· health
· 4 min de lectura
High
Verificación: Verificado
After 18 years of misdiagnosis, teen finally gets answer: Jordan syndrome
Lucia experienced 18 years of undiagnosed symptoms including seizures, fainting spells, concussions, and developmental delays that disrupted her education, social life, and mental health until diagnosis.
◉
Health & Medicine
7994 artículos relacionados
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 100% coincidencia
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% coincidencia
Canada faces new COVID epidemic, not third wave, as variants target di…
The Globe and Mail · 99% coincidencia
Researchers identify new Ebola variant, propose repurposed drug treatm…
Medical Xpress · 99% coincidencia
Dalhousie researchers identify new Ebola variant, propose repurposed d…
Education News Canada · 99% coincidencia
Cobertura Relacionada
The Guardian · Aug 18
ADHD diagnosis surge raises questions about identity versus disorder
Experts warn that rising ADHD diagnoses increasingly reflect identity-seeking rather than medical need, with poor-qualit…
BBC News · Aug 18 BBC investigation expands: 30 children feared conceived with wrong donors at Cyprus IVF clinicsAt least 30 children, mostly British, are feared conceived via IVF in northern Cyprus using wrong sperm or egg donors th…
News-Medical · Aug 18 IV Iron Use Among Australian Women Surges 17-Fold in DecadeAustralian women's intravenous iron use jumped 17-fold in a decade, with 1 in 20 reproductive-age women receiving treatm…
geneonline.com · Aug 18 1 in 20 Australian Women Now Receiving IV Iron InfusionsOne in 20 Australian women now receive intravenous iron infusions, marking a significant decade-long increase in this tr…
Sesgo y Encuadre
⚖
Human interest story with positive medical resolution framing; presents Cleveland Clinic favorably while emphasizing patient/family perseverance without critical examination of diagnostic failures.
Bias Direction
center
Confidence
MED
Inspirational medical mystery narrative with emphasis on triumph-over-adversity and institutional competence. Frames the 18-year diagnostic delay as a problem solved rather than a systemic failure to examine.
determined to find out
no way this one child has all of these labels
out-of-the-box solutions
upended her life
stack of medical records was getting bigger and bigger
No one listened to me
Perspective from the multiple doctors/specialists who provided earlier misdiagnoses and their reasoning
Healthcare system critique regarding diagnostic delays for rare diseases
Cost/financial burden of 18 years of misdiagnosis and unnecessary treatments
Prevalence and accessibility of genetic sequencing for undiagnosed cases
Expert commentary on why Jordan syndrome is so frequently missed
Lucia's current prognosis and whether the diagnosis enables meaningful treatment improvements
Impacto Geopolítico
🌎
This is a medical human interest story about rare disease diagnosis, not a geopolitical matter.
Escalation Risk
N/A
Confidence
HIGH
Lente Económico
📈
Rare genetic disorder diagnosis has minimal direct economic impact but highlights healthcare system inefficiencies in diagnostic processes and potential future market for rare disease treatments.
Market Signal
neutral
Confidence
MED
Healthcare/Medical Services
Genetic Testing/Diagnostics
Pharmaceutical/Biotech
Medical Education
Consumers may face continued high costs from misdiagnosis cycles and multiple specialist visits; highlights need for improved diagnostic pathways and potential insurance coverage gaps for genetic sequencing services.
May prompt healthcare policy review regarding: (1) insurance coverage for advanced genetic testing in diagnostic workups, (2) medical education standards for rare disease recognition, (3) undiagnosed disease clinic funding and accessibility, (4) incentives for pharmaceutical development of ultra-rare disease treatments.